Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / Pneumagen Ltd, a subsidiary of NorthLinks Bio

Clinicaltrial registered27 Oct 2026

Pneumagen Ltd, a subsidiary of NorthLinks Bio

27 Oct 2026: Trial registered · Nasal Residency of HEX17. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
27 Oct 2026
Title
Nasal Residency of HEX17
Conditions
Healthy Volunteers
Phase
Phase 1
Study Type
Interventional
Status
Not Yet Recruiting
Countries
United Kingdom
Country
United Kingdom
Reference
NCT07898306
Location
United Kingdom
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Pneumagen Ltd, a subsidiary of NorthLinks Bio

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

More from United Kingdom

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.